Clinical trial Recruiting at 1 site Observational Ages 18 to 85

Comparing cardiovascular events in stroke patients with and without sleep-disordered breathing

Official title: Sleep Apnea Syndrome and Incidence of Major Adverse Cardiac and Cerebrovascular Events (MACCEs) After a First Stroke

Run by University Hospital, Grenoble · NCT04399200 · Data updated 2026-11-12

This study is trying to see if having sleep-disordered breathing affects the risk of heart and brain problems in stroke patients over the next year.

More Stroke trials

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment1620 (estimated)
SponsorUniversity Hospital, Grenoble
Academic / other
Locations1 site (Grenoble)
StatusRecruiting
StartedJuly 13, 2020
Main results expectedJune 1, 2030
Study endsJune 1, 2035
Registry record updatedFebruary 11, 2025
Trial IDNCT04399200 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 85 who have experienced a first stroke or TIA within 72 hours and have a modified Rankin Scale score of 1 or less prior to the event.

Probably not a fit

Patients with a history of stroke, ongoing treatment for sleep-disordered breathing, or those unable to follow rehabilitation procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cohort study aims to evaluate the incidence of cardiac and cerebrovascular events in patients who have experienced a first stroke or transient ischemic attack (TIA) and have been diagnosed with sleep-disordered breathing (SDB). The study will include 1620 patients, who will undergo polysomnography three months after their cerebrovascular event to determine SDB status based on an Apnea-Hypopnea Index (AHI) greater than 15 events/hour. The primary outcome will assess the occurrence of major adverse cardiovascular events, including death from cardiac or cerebrovascular causes, non-fatal strokes, and non-fatal acute coronary events, one year after SDB diagnosis. Secondary outcomes will include various clinical and cognitive assessments over a five-year follow-up period.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for stroke patients with sleep-disordered breathing, potentially reducing the risk of subsequent cardiovascular events.

How similar studies have gone: While there have been studies examining the relationship between sleep-disordered breathing and cardiovascular events, this specific approach of comparing SDB and non-SDB patients post-stroke is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female, aged 18 to 85 years
* Admitted in the stroke unit no later than 72h after the onset of stroke symptoms:

  * First stroke confirmed by computed tomography scan or magnetic resonance imaging, whatever the localization
  * Initial or recurrent TIA, as defined by a brief and sudden neurological dysfunction for which an ischemic cause is presumed, with symptoms lasting less than 24 hours, and/or with no visible lesion on neuroimaging evaluation.
* Score on the Modified Ranking scale (mRS) ≤1 before stroke
* Signed informed consent by patient or his/her relative if not able
* Patient eligible to carotid endarterectomy (for ancillary study only)

Exclusion Criteria:

* Pregnant or breastfeeding women
* Past history of stroke
* Inability to follow rehabilitation procedure
* Patients with ongoing treatment for SDB
* Exclusion period for another study
* Patients not affiliated to a French social and health insurance system or equivalent
* Prisoners or patients who require protection by the law

Where it's running

  • University Hospital Grenoble
    Grenoble, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.